How to read: Every bubble is one Indian ambroxol exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Ambroxol report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial ambroxol trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian ambroxol suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Ambroxol India trade report
P
Product scope
Ambroxol
All variants merged — branded and generic formulations of ambroxol
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
105
Every commercial ambroxol trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $272.9K, Nov $220.3K, Dec $168.3K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$272.9K
Oct USD
25 shipments
2
$220.3K
Nov USD
-19.3% MoM
3
$168.3K
Dec USD
-23.6% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 19.3% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $273K, making it the strongest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: ARISTO PHARMACEUTICALS PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import ambroxol from India, how much they buy, and who supplies each market
KEY TAKEAWAYRussia absorbs 19.7% of India’s 2025-Q4 ambroxol trade ($130.2K). Beyond the top 10 destinations, 27 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 10 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 27 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much ambroxol India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$180K
27.2% of trade
10 countries · 27 shipments
Europe
$169K
25.6% of trade
3 countries · 8 shipments
Americas
$131K
19.8% of trade
5 countries · 14 shipments
Africa
$181K
27.4% of trade
9 countries · 54 shipments
Oceania
$138
0.0% of trade
1 countries · 2 shipments
Fig 4.1 Russia is the #1 corridor ($130K) — 28 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian ambroxol it receives (light = low, dark = high). Orange arcs radiate from India to the top 28 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Russia
$130K
3
SUN PHARMACEUTICAL INDUSTRIES LTD
$91K
INTIGREAT CONSULTING SERVICES LLP
$39K
—
—
2
Uganda
$79K
3
S KANT HEALTHCARE LTD
$79K
—
—
—
—
3
Tanzania
$65K
6
ARISTO PHARMACEUTICALS PVT LTD
$48K
BRYAN & CANDY (I) PVT LTD
$9K
STANMARC ENTERPRISE
$5K
4
Philippines
$52K
2
BDH INDUSTRIES LTD
$37K
INVENTIA HEALTHCARE LTD
$15K
—
—
5
Venezuela
$49K
5
SAGA LIFESCIENCES LTD
$31K
LIVEALTH BIOPHARMA PVT LTD
$11K
ALDE MEDI IMPEX LTD
$7K
6
Uruguay
$39K
3
XL LABORATORIES PVT LTD
$39K
—
—
—
—
7
Poland
$33K
4
SAVA HEALTHCARE LTD
$33K
—
—
—
—
8
Nepal
$31K
5
GLENMARK PHARMACEUTICALS LTD
$26K
ARISTO PHARMACEUTICALS PVT LTD
$5K
—
—
9
Vietnam
$30K
3
GRACURE PHARMACEUTICALS LTD
$26K
ONTO HEALTHCARE
$2K
HINDAZ.CORP
$2K
10
Tajikistan
$29K
8
INFUGEN PHARMA PVT LTD
$13K
KWALITY PHARMACEUTICALS LTD
$7K
ELCON DRUGS AND FORMULATIONS LTD
$3K
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 27.2% of USD — but Russia is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
19.7%
#1 country share
Russia alone
56.7%
Top 5 share
5 of 28 countries
93.6%
Top 15 share
Long tail of 13 countries = 6.4%
HHI 902
Destination HHI
Competitive spread
28
Countries served
Global pharma reach from India
10
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
45 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYSUN PHARMACEUTICAL INDUSTRIES LTD ($90.8K, 13.7% share) and S KANT HEALTHCARE LTD ($79.0K) together control 25.7% of India’s 2025-Q4 ambroxol trade. The top 5 suppliers hold 45.9%. 45 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian ambroxol suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 SUN PHARMACEUTICAL INDUSTRIES LTD leads by $12K over S KANT HEALTHCARE LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SHAIMIL LABORATORIES is #20 by value but #9 by volume.
Fig 5.2 ARISTO PHARMACEUTICALS PVT LTD also leads by shipment count (22) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SHAIMIL LABORATORIES moves from #9 by volume to #20 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 45 ambroxol suppliers split into strategic segments
KEY TAKEAWAY12 suppliers (25%) generate 74.9% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 SUN PHARMACEUTICAL INDUSTRIES LTD and S KANT HEALTHCARE LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 74.9% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
43 importers across 28 countries — who is buying Indian ambroxol and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 70.8% of total USD. 98% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian ambroxol. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 AO RANBAXY"107023, MOSCOW, ELECTRO is the #1 importer at $91K (13.7%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian ambroxol prices vary by supplier, country and dosage form
KEY TAKEAWAYAmbroxol prices span 34415× ($0.0018 → $62.72). The coefficient of variation is 4.43. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. ARISTO PHARMACEUTICALS PVTSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SUN PHARMACEUTICAL INDUSTRIESSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Nov 2025
REGAL LABORATORIES
Equatorial Guinea
Tablet
266
$17K
$62.72
Specialty / small-batch
Dec 2025
JPC GLOBAL
Australia
Tablet
3
$134.79
$44.93
Specialty / small-batch
Oct 2025
AKASH PHARMA EXP…
Chad
Injection
50
$173.63
$3.47
Sterile formulation premium
Dec 2025
SAVA HEALTHCARE …
Mauritius
Tablet
1
$2.73
$2.73
Specialty / small-batch
Dec 2025
SAVA HEALTHCARE …
Mauritius
Tablet
10
$27.29
$2.73
Specialty / small-batch
Nov 2025
SAVA HEALTHCARE …
Mauritius
Tablet
2
$5.40
$2.70
Specialty / small-batch
Nov 2025
SAVA HEALTHCARE …
Mauritius
Tablet
13
$34.96
$2.69
Specialty / small-batch
Nov 2025
SAVA HEALTHCARE …
Mauritius
Tablet
1
$2.69
$2.69
Specialty / small-batch
Nov 2025
SAVA HEALTHCARE …
Mauritius
Tablet
3
$8.07
$2.69
Specialty / small-batch
Oct 2025
KUSUM HEALTHCARE…
Uzbekistan
Tablet
4K
$7K
$1.86
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
DEN MARK PHARMAC…
Somalia
Syrup
50
$0.091
$0.0018
Small sample / trial shipment
Dec 2025
DEN MARK PHARMAC…
Somalia
Syrup
300
$0.547
$0.0018
Small sample / trial shipment
Dec 2025
DEN MARK PHARMAC…
Somalia
Syrup
100
$0.228
$0.0023
Small sample / trial shipment
Dec 2025
ZEST PHARMA
Kenya
—
5K
$20.99
$0.0043
Dec 2025
CUIDADO MEDICO P…
Mauritius
Tablet
100
$0.663
$0.0066
Bulk generic tablet
Dec 2025
ARISTO PHARMACEU…
Kenya
Drops
20K
$138.34
$0.0069
Dec 2025
ARISTO PHARMACEU…
Kenya
Drops
2K
$13.83
$0.0069
Dec 2025
ARISTO PHARMACEU…
Kenya
Syrup
2K
$19.18
$0.0096
Dec 2025
ARISTO PHARMACEU…
Kenya
Syrup
20K
$191.84
$0.0096
Dec 2025
SAVA HEALTHCARE …
Mauritius
Tablet
6
$0.183
$0.030
Small sample / trial shipment
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship ambroxol, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYAmbroxol leaves India through 14+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), MUNDRA SEA, MUMBAI AIR (SAHAR)) handle 83.3% of total USD. SEA moves 61% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $328K — top 14 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 61% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$429K
64.8% of USD · 61.0% of ships
ICD
$144K
21.8% of USD · 16.2% of ships
AIR
$57K
8.7% of USD · 18.1% of ships
ROAD
$31K
4.7% of USD · 4.8% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($147K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYSomalia is the most concentrated destination (HHI 10000, 1 suppliers). Tajikistan is the most competitive (HHI 2897).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Somalia (HHI 10,000) is the most concentrated — Tajikistan (HHI 2,897) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
AO RANBAXY"107023, M…
Russia
SUN PHARMACEUTIC…
$91K
1
MEDIUM
OOO S PHARMA
Russia
INTIGREAT CONSUL…
$39K
1
MEDIUM
SAN FERNANDO SRL
Uruguay
XL LABORATORIES …
$39K
3
MEDIUM
NELPA LIFESCIENCES INC
Philippines
BDH INDUSTRIES LTD
$37K
1
MEDIUM
TO PARTY PLANET PHAR…
Tanzania
ARISTO PHARMACEU…
$27K
2
MEDIUM
PHUC CUONG PHARMA JO…
Vietnam
GRACURE PHARMACE…
$26K
1
MEDIUM
FARMANURA PVT LTD
Nepal
GLENMARK PHARMAC…
$26K
2
MEDIUM
PLANET PHARMACEUTICA…
Tanzania
ARISTO PHARMACEU…
$21K
1
MEDIUM
Conclusion: 41 buyers depend on exactly one Indian supplier, representing $487K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Russia
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Uganda
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Tanzania
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Philippines
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Venezuela
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Uruguay
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Poland
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Nepal
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Vietnam
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Tajikistan
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Chile
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Bolivia
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Equatorial Guinea
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Myanmar
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Angola
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Russia
This Q
HIGH
A2
Offer alternative to top multi-source buyer
This Q
HIGH
A3
Audit Somalia lock-ins (HHI 10000)
This Q
MED
A5
Enter Russia (2 suppliers)
This Q
HIGH
A6
Enter Uganda (1 suppliers)
This Q
MED
A8
Build Uganda distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for Russia tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Russia
Other
2
$130K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
2
Uganda
Africa
1
$79K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Tanzania
Africa
4
$65K
-18.8%
LOW
Low competition (4 suppliers), accessible market
4
Philippines
Asia
2
$52K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
5
Venezuela
Other
3
$49K
-30.3%
LOW
Low competition (3 suppliers), accessible market
6
Uruguay
Other
1
$39K
-70.8%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
Poland
Other
1
$33K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Nepal
Asia
2
$31K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
9
Vietnam
Asia
3
$30K
0%
LOW
Low competition (3 suppliers), accessible market
10
Chile
Other
1
$20K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Bolivia
Other
1
$18K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Equatorial Guinea
Africa
1
$17K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Myanmar
Asia
2
$13K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
14
Angola
Africa
3
$13K
-33%
LOW
Low competition (3 suppliers), accessible market
15
Georgia
Other
1
$8K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 105 2025-Q4 Ambroxol shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ambroxol
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 105 2025-Q4 ambroxol shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian ambroxol shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
105
across all regions
TOTAL USD
$661K
2025-Q4 FOB value
UNITS
1.4M
tablets, capsules, etc.
SUPPLIERS
45
Indian exporters
BUYERS
43
global importers
COUNTRIES
28
destinations
§10.2 Regional breakdown
Africa
$181K
27.4%
9 ctry · 54 ships
Asia
$180K
27.2%
10 ctry · 27 ships
Europe
$169K
25.6%
3 ctry · 8 ships
Americas
$131K
19.8%
5 ctry · 14 ships
Oceania
$138.49
0.0%
1 ctry · 2 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $181K (27.4%), spanning 9 countries.
🏢
45 Indian suppliers shipped to 43 buyers across 28 countries — average shipment value $6K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 41 global ambroxol importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian ambroxol in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
AO RANBAXY"107023, MOSCOW, ELECTRO
Russia
1
$91K
SUN PHARMACEUTICAL I…
Syrup
2
OOO S PHARMA
Russia
1
$39K
INTIGREAT CONSULTING…
Syrup
3
SAN FERNANDO SRL
Uruguay
3
$39K
XL LABORATORIES PVT …
Tablet
4
NELPA LIFESCIENCES INC
Philippines
1
$37K
BDH INDUSTRIES LTD
Capsule
5
TO PARTY PLANET PHARMACEUTICAL LTD
Tanzania
2
$27K
ARISTO PHARMACEUTICA…
Syrup
6
PHUC CUONG PHARMA JOINT STOCK
Vietnam
1
$26K
GRACURE PHARMACEUTIC…
Solution
7
FARMANURA PVT LTD
Nepal
2
$26K
GLENMARK PHARMACEUTI…
Syrup
8
PLANET PHARMACEUTICAL LTD
Tanzania
1
$21K
ARISTO PHARMACEUTICA…
Syrup
9
OPKO CHILE S.A
Chile
1
$20K
SANPRAS HEALTHCARE P…
Syrup
10
LABORATORIOS ALFA S. A
Bolivia
4
$18K
WEXFORD LABORATORIES…
Syrup
11
MOVI HEALTH LLC
Poland
2
$17K
SAVA HEALTHCARE LTD
Tablet
12
SONIA PHARMACY
Equatorial Guinea
1
$17K
REGAL LABORATORIES
Tablet
13
I.E. MEDICA INC
Philippines
1
$15K
INVENTIA HEALTHCARE …
14
PHARMED LTD
Tanzania
1
$9K
BRYAN & CANDY (I) PV…
Syrup
15
THE MAIN PHARMACEUTICALS ASSOCIATIO
Georgia
1
$8K
GLOW PHARMA PVT LTD
Tablet
16
LEGEND CREATIVES CO LTD
Myanmar
2
$7K
SHAIMIL LABORATORIES
Syrup
17
CASA DE REPRESENTACION SA
Venezuela
3
$7K
ALDE MEDI IMPEX LTD
Suspension
18
FE BARAKA DORI FARM LLC
Uzbekistan
1
$7K
KUSUM HEALTHCARE PVT…
Tablet
19
LLC SOLIM PHARM
Tajikistan
1
$7K
KWALITY PHARMACEUTIC…
Syrup
20
M/S.RAMMAWADDY INTERNATIONAL CO LTD
Myanmar
1
$6K
FOURRTS (INDIA) LABO…
Syrup
21
UNIQUE TRADE LINK PVT LTD
Nepal
3
$5K
ARISTO PHARMACEUTICA…
Drops, Syrup
22
TOTHE ORDER R.D.CONGO
Tanzania
1
$5K
STANMARC ENTERPRISE
Syrup
23
LLP DARI-PHARM (KAZAKHSTAN)BUILDIN
Kazakhstan
1
$5K
KUSUM HEALTHCARE PVT…
Tablet
24
UNIPLUS FARMA,LDA
Angola
2
$4K
ANETA PHARMACEUTICAL…
Syrup
25
SWAGAT DIST. CO LTD
Cambodia
1
$3K
MEDWAY HEALTHCARE
Syrup
26
LLC VORISI SINO
Tajikistan
2
$3K
ELCON DRUGS AND FORM…
Syrup
27
STE. SIMCO S.A
Kenya
2
$3K
AURA LIFECARE PVT LTD
Syrup
28
MADAD PHARM LLC
Tajikistan
1
$2K
EVOLET HEALTHCARE PV…
Tablet
29
ARAUPHAR S.A
Tanzania
1
$2K
AURA LIFECARE PVT LTD
Syrup
30
AMDJERAS FIELD HOSPITAL
Chad
3
$2K
AKASH PHARMA EXPORTS
Injection, Syrup
31
IMRAN PHARMA CO LTD
Vietnam
1
$2K
HINDAZ.CORP
Syrup
32
THE ORDER OF TAJIKISTAN. . TAJIKIST
Tajikistan
1
$2K
OM BIOMEDIC PVT LTD
Syrup
33
CUREPHARM LTD
Mauritius
2
$2K
CUIDADO MEDICO PVT LTD
Tablet
34
TRIDEM PHARMA KENYA LTD
Kenya
8
$1K
ARISTO PHARMACEUTICA…
Syrup, Drops
35
EMIRATES POST GROUP
United Arab Emirates
2
$443.15
DEEP IMPEX
Tablet
36
NORVIK ENTERPRISES LTD
Kenya
8
$363.20
ARISTO PHARMACEUTICA…
Drops, Syrup
37
TO THE, IMPORTING DEPARTMENT
Australia
1
$134.79
JPC GLOBAL
Tablet
38
REGENCY EXIM TRADE LTD
Mauritius
7
$81.31
SAVA HEALTHCARE LTD
Tablet
39
UNIQUE PHARMA
Kenya
1
$20.99
ZEST PHARMA
40
TO THE INVOICE RAISED TO MANGER OF
Seychelles
1
$6.70
DRIVECURE HEALTHCARE…
Syrup
41
AO RANBAXY
Russia
1
$0.0000
SUN PHARMACEUTICAL I…
Syrup
This report covers 105 2025-Q4 Ambroxol shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ambroxol
Talk to our trade analyst
Need a custom ambroxol report or a deeper dive into any market? Our team is ready.